Three academic scientists jointly won the 2004 Nobel Prize for research into ubiquitin ligases, and Rigel Pharmaceuticals Inc. is taking home an "award" of its own - a deal with Merck & Co. Inc. to investigate the new class of drugs for cancer therapies and others. (BioWorld Today)